Guven, D. C. Et Al. 2023. Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment. Expert Review of Anticancer Therapy , vol.23, no.10 , 1049-1059.

Guven, D. C., YILDIRIM, H. Ç., KUŞ, F., Erul, E., KERTMEN, N., DİZDAR, Ö., ... AKSOY, S.(2023). Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment. Expert Review of Anticancer Therapy , vol.23, no.10, 1049-1059.

Guven, DENİZ Et Al. "Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment," Expert Review of Anticancer Therapy , vol.23, no.10, 1049-1059, 2023

Guven, DENİZ C. Et Al. "Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment." Expert Review of Anticancer Therapy , vol.23, no.10, pp.1049-1059, 2023

Guven, D. C. Et Al. (2023) . "Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment." Expert Review of Anticancer Therapy , vol.23, no.10, pp.1049-1059.

@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment}, journal={Expert Review of Anticancer Therapy}, year=2023, pages={1049-1059} }